>>MSCI – Two additions to MSCI Indonesia: Charoen Pokphand Indonesia (CPIN) and Kalbe Farma (KLBF). Estimated buying volume for CPIN is 43.5mn shares, for KLBF is 133mn shares.>>>
"إِنَّا مَكَّنَّا لَهُۥ فِى ٱلْأَرْضِ وَءَاتَيْنَهُ مِن كُلِّ شَىْءٍۢ سَبَبًۭا فَأَتْبَعَ سَبَبًا Sesungguhnya Kami telah memberi kekuasaan kepadanya di (muka) bumi, dan Kami telah memberikan kepadanya jalan (untuk mencapai) segala sesuatu, maka diapun menempuh suatu jalan." (QS. AL KAHFI:84-85)
>> Saham Agung Podomoro Dilepas Rp365 per Unit >>> INDY: After mkt close the major shareholders placed out a USD 200m block of stock, or about 10% of cap at 3675 (range 3600-3725) at a 5.7% discount. The placement was said to be 3X subscribed to.

My Family

Minggu, 12 September 2010

CLSA Bank Danamon up 4.7% on the back of DBS raising US$10bn debt

DBS announced this morning an intent to raise US$10bn in senior debt. Please see below, comment from Bret Ginesky.
DBS announced this morning an intent to raise US$10bn in senior debt
While this raise was announced in June today the bank appointed investment banks to sell the offering.
DBS is formally stating that this is for "general funding" purposes
We believe funds could be used to purchase Temasek's 76% in Bank Danamon
Bank Danamon rose 4.7% today on heavy trading of US$12m
We believe Danamon shares could fetch 3.0x book or higher, reflecting a share price of Rp6,400 or higher, which is 15% upside from today's close
While we currently rate the stock an underperform, M&A speculation will continue to drive the shares higher. Our rec is under review.
Please see additional comments by Singaporean bank analyst Derek Ovington:

I think it's important to stress that there's an innocuous explanation for DBS raising so much debt, and that is to fund its growing balance sheet at relatively low cost given low bond yields right now.

However, as Bret points out the BDMN trading suggests there could be more to it than that.

Attached is the note that I wrote on the DBS-BDMN hypothetical. While the deal would be prima facie dilutive, and materially so, the note also shows that DBS could leverage up to mask the dilution and make a 3x book deal at least look more palatable. That's why I can't discount the possibility of a transaction.

I still think there's a low probability that DBS/Temasek will do it, but I may be over-rating their commercial judgement and/or under-rating their strategic desire.

In my view, M&A risk is just another reason to sell DBS (U-PF). It's expensive, has the weakest return profile and is the Singapore bank most exposed to margin downside.

Tidak ada komentar:

Posting Komentar

Yahoo! Finance: Top Stories

Reuters: Business News

Insider Stories

CNBC Top News and Analysis

» Ekobiz

The Wall Street Journal

AnggunTraders.com

Commodity Online Metals News

Britama.com

Palm Oil Prices

Commodities-Markets-The Economic Times

Detikfinance

BusinessWeek.com -- Top News

Palm Oil HQ Daily Update

Business Times : marketwatch

VIVAnews - BISNIS

The Star Online: Business

Inilah.com -

Latest financial news - CNNMoney.com

Tempointeraktif.com - Bisnis

ChinaDaily > bizchina

Sindikasi economy.okezone.com

Commodity News

Bursa Rumor - Tempatnya Investor Saham Cari Berita

Financial Times - Financial markets news

Hellenic Shipping News

ANTARA - Ekonomi & Bisnis

Industrial Metals & Minerals Industry News

Republika Online - Ekonomi

Yahoo Commodities News